Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

Christenson B., Hedlund J., Lundbergh P., Ortqvist A.

Source: Eur Respir J 2004; 23: 363-368
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christenson B., Hedlund J., Lundbergh P., Ortqvist A.. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004; 23: 363-368

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Pneumococcal and influenza vaccination
Source: Eur Respir Monogr 2014; 63: 266-284
Year: 2014


Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Influenza and pneumococcal vaccination
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Source: Eur Respir J 2005; 26: 1086-1091
Year: 2005



Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018

Should pneumococcal vaccines be used to prevent LRTI?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009

Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly
Source: Eur Respir J 2010; 36: 608-614
Year: 2010



Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005

Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


Impact of influenza vaccination in patients with CAP
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
Source: Eur Respir J 2015; 46: 1407-1416
Year: 2015



The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

The relation of people to vaccination against an influenza virus
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010

Influenza: vaccination and treatment
Source: Eur Respir J 2001; 17: 1282-1293
Year: 2001